XML 41 R26.htm IDEA: XBRL DOCUMENT v3.25.3

STOCK OPTIONS, RESTRICTED STOCK AND WARRANTS (Tables)

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Schedule of stock options

Schedule of stock options
		Options Outstanding
											Weighted -
											Average
											Remaining				Aggregate
							Weighted-				Contractual				Intrinsic
			Number of				Average				Term				Value
			Shares				Exercise Price				(in years)				(in thousands)(1)
Balance as of December 31, 2024			221,000			$	3.57				0.4			$	-
Granted			-				-
Forfeited/Cancelled/Expired			(221,000	)			3.57
Balance as of September 30, 2025			-			$	-				-			$	-
Exercisable as of September 30, 2025			-			$	-				-			$	-

Schedule of unvested restricted stock awards

Schedule of unvested restricted stock awards
						Weighted -
						Average
		Number of				Grant
		Award Shares				Date Fair Value
Unvested at December 31, 2024			140,000			$	1.60
Granted			-				-
Vested			(140,000	)			1.60
Balance at September 30, 2025			-			$	-

Schedule of unvested restricted stock units

Schedule of unvested restricted stock units
						Weighted -
						Average
		Number of				Grant
		Unit Shares				Date Fair Value
Unvested at December 31, 2024			273,736			$	1.38
Granted			110,773				1.52
Vested			(155,038	)			1.44
Forfeited			(20,334	)			1.57
Balance at September 30, 2025			209,137			$	1.39

Schedule of unvested performance restricted stock units

Schedule of unvested performance restricted stock units
						Weighted -
						Average
		Number of				Number of
		Unit Shares				Unit Shares
Unvested at December 31, 2024			1,606,660			$	1.37
Granted			-				-
Forfeited/Cancelled			(285,069	)			2.40
Balance at September 30, 2025			1,321,591			$	1.15

Schedule of warrants outstanding

Schedule of warrants outstanding
		Number of Warrant Shares				Weighted- Average Exercise Price				Weighted - Average Remaining Contractual Term (in years)				Aggregate Intrinsic Value (in thousands)(1)
Balance as of December 31, 2024			4,628,586				4.13				1.2
Issued			1,461,896				4.00
Exercised			(1,461,896	)			3.22
Expired			(3,073,379	)			4.60
Balance as of September 30, 2025			1,555,207			$	3.95				4.6
Exercisable as of September 30, 2025			1,555,207			$	3.95				4.6			$	-

(1) The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.89 for our common stock on September 30, 2025.

Schedule of assumptions used

Schedule of assumptions used
		January 13, 2025
Risk free interest rate		4.34%
Expected life		2.75 years
Expected volatility		171%
Expected dividend		-

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested performance-based units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in restricted stock units (RSUs).

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration